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Abstract
Invasive fungal infection is rarely reported in association with malaria, even though malaria-
associated inhibition of phagocyte function is a well-known condition. Invasive aspergillosis is
frequently found in severely immuno-compromised patients but not in healthy individuals. Here, a
case of pulmonary invasive aspergillosis in a previously healthy patient with severe P. falciparum
malaria is presented, who was successfully treated with voriconazol and caspofungin. This is the
first survival of malaria-associated invasive aspergillosis.
Background
There is strong evidence that malaria can lead to altered
immune response via modulation of both humoral and
cell-mediated immunity. Therefore, Plasmodium falci-
parum  malaria with subsequent transient immunosup-
pression can lead to opportunistic infections in previously
immunocompetent patients [1].
Aspergillosis (Aspergillus spp.) is a major cause of morbid-
ity and mortality in immuno-suppressed hosts, such as
patients with haematological malignancies and transplant
recipients. Aspergillus  spp. is found ubiquitously in the
environment worldwide and reaches the alveoli by air-
borne transmission. In healthy persons, the spores are
eliminated by mucociliary clearance and pulmonary mac-
rophages. Although infection in healthy individuals can
occur, invasive aspergillosis is extremely uncommon in
immuno-competent hosts. There are only four reported
cases of invasive aspergillosis complicating falciparum
malaria in immuno-competent hosts, all with fatal out-
come [2-4].
Case presentation
A 58-year old Caucasian man returned from an 11-day
vacation in the Dominican Republic. He had no previous
medical history and no malaria prophylaxis was taken.
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Six days after return, he developed a fever of up to 40.5°C
and dark-coloured watery diarrhoea with nausea and
vomiting. His general practitioner suggested a viral infec-
tion and treated him with ibuprofen. The fever remained
high and on the 7th day of illness, his general condition
deteriorated. On presentation at the hospital, he addition-
ally was complaining of pain upon swallowing.
On admission, he was sleepy, but fully oriented, afebrile
and pale. No signs of meningitis were found. The lungs
were clear and the heart sounds normal. BP was 150/85
mmHg and the pulse rate 95/min. Blood films showed P.
falciparum with a parasitaemia of 9.5%. Initial laboratory
results were Hb 14.6 g/dl, WBC 8.14/nl, PLT 12/nl, CRP
162.8 mg/l (normal range < 5 mg/l), creatinine 6.09 mg/
dl, urea 208 mg/dl, LDH 805 U/l, GOT 69 U/l, GPT 197
U/l. Blood culture, urine culture and serology for hepatitis
A, B, C and HIV were negative. Chest x-ray and ultrasound
were unremarkable except for mild hepatosplenomegaly.
Pharyngitis sicca was diagnosed by the ENT consultant.
Treatment with quinine i.v. was initiated with a loading
dose of 7.0 mg/kgBW and continued at a rate of 10 mg/
kgBW every eight hours for four hours over 10 days. Para-
sitaemia decreased to 2.7% within three days and was
cleared by day five. He was put on intermittent hemodial-
ysis after developing acute renal failure. Antibiotic cover-
age with imipenem was started.
On day 5 of hospitalization, respiration deteriorated and
the patient was intubated. The chest x-ray revealed patchy
infiltrates of the upper left lobe and on bronchoscopy
bronchial obstruction with viscous mucus was seen. This
was cleared and in the material obtained Aspergillus fumi-
gatus was cultured abundantly. The circulating antigens of
0.8 remained below the positive cut-off of 1.0 given by the
laboratory. The anti-Aspergillus  antibody titre remained
below the positive cut-off of 1:160 – 1:320. Therapy with
voriconazol and caspofungin was started immediately.
In the following days respiration improved. On day 7 of
artificial ventilation, however, severe haemoptysis sud-
denly precipitated with cardio-pulmonary arrest. He was
successfully resuscitated and pulmonary bleeding sponta-
neously stopped. A thoracic CT scan showed multiple
confluent ground glass-infiltrates of both lungs and
enlarged mediastinal and hilar lymph nodes (Figure 1A).
Bronchoscopy was performed and showed obstruction of
the right main bronchus and lower lobe with coagulated
blood. After removal, at the carina tracheae necrotic
lesions became apparent and multiple sharply circum-
scribed ulcerations were found in the bronchi of both
upper lobes, suggesting pseudo-membranous necrotizing
aspergillosis (Figures 1B and 1C). Pathological examina-
tion of the specimen confirmed the diagnosis. PAS-stain-
ing showed mycelia with dichotomy branching and
partially septated hyphae with extensive invasive growth
typical for Aspergillus spp. (Figures 1D to 1G). With broad
spectrum antibiotic coverage and antifungal therapy with
voriconazol and caspofungin, infection parameters
decreased, respiration improved and he recovered from an
infectious point of view. However, a cranial CT revealed
hypoxic brain damage following CPR.
Conclusion
Aspergillosis, in particular the invasive course of the dis-
ease, is only seen in patients with severe immuno-sup-
pression and has a very poor prognosis. In individuals
without severe immuno-suppression, invasive fungal
infections are extraordinarily rare. Till date invasive
aspergillosis during P. falciparum malaria has only been
described in four cases, none of which survived [2-4]. Two
other cases of invasive fungal infections associated with P.
falciparum malaria had disseminated candidiasis and cryp-
tococcal meningitis [5,6].
Falciparum  malaria can lead to suppression of both
humoral and cell-mediated immunity. Humoral immu-
nity is impaired through reduced production of specific
antibodies, while cell-mediated immunity is modulated
by inhibition of dendritic cells, which is crucial as they ini-
tiate all adaptive and several innate immune responses,
and also impairment of T cell and macrophage function
plays a role [1,7,8].
Inhibition of key enzymes involved in oxidative burst by
the malaria-pigment haemozoin seems to be one of the
most important mechanisms contributing to the disrup-
tion of macrophage function. Both in vitro and in vivo
studies showed that large proportions of resident macro-
phages as well as circulating monocytes and leucocytes are
loaded with haemozoin and consequently lose their abil-
ity to phagocytose and kill ingested germs such as fungi
[9]. Especially the latter seems to play a role in invasive
fungal infection, because pulmonary macrophages are the
major line of defence for Aspergillus spp., as they are elim-
inating spores from the lungs [10]. The central role of
phagocytes in the defence of fungal infections is under-
lined by the following observation: In patients suffering
from chronic granulomatous disease, an inherited immu-
nodeficiency due to a NADPH oxidase defect, Aspergillus
spp. is the most frequent fungal pathogen and pneumonia
the major cause of death, because here phagocytes fail to
generate reactive antimicrobial oxidants which impairs
oxidative burst [11]. The malaria-induced inhibition of
macrophages seems to appear late in the acute phase of
the disease and persists for various lengths of time after
recovery, as haemozoin stays in the affected macrophages
for several months [10]. While haemozoin induces func-
tional inhibition of macrophages, the availability of mac-Malaria Journal 2009, 8:167 http://www.malariajournal.com/content/8/1/167
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A: Thoracic CT scan Figure 1
A: Thoracic CT scan. Multiple confluent ground glass-infiltrates in both lungs due to Aspergillus fumigatus. B and C: Bron-
choscopic findings. B: Sharply circumscribed lesion of the carina tracheae of the upper left lobe, extending into the upper 
lobe bronchus. C: Extensive necrosis of the bronchial wall extending into the periphery up to segment 2 of the upper right 
lobe. D-G: Histological findings of the transbronchial biopsy. D: Overview of the biopsy specimen, HE stain, primary 
magnification × 5. The black box indicates the area shown in E, primary magnification × 20: PAS staining showing extensive 
invasive growth of hyphae into the bronchial wall (black arrows). F: Mycelia of Aspergillus fumigatus with dichotomy branching 
(black arrows) with inflammatory infiltrates and necrosis (white arrows), PAS stain, primary magnification × 10. G: Extensive 
fungal growth with partially septated hyphae (black arrows), PAS stain, primary magnification × 20.Malaria Journal 2009, 8:167 http://www.malariajournal.com/content/8/1/167
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rophages at the site of infection (in the case presented the
lung) is questionable, as during malaria infection macro-
phages in the blood are likely concentrated where parasi-
tized red blood cells are concentrated. These organs
include spleen, liver and bone marrow, but not the lung.
In the case presented, as in the four other published cases,
inhibition of macrophages leading to aspergillosis was
most likely malaria-associated as no other cause was
found. Other mechanisms such as inhibition of humoral
and antigen-specific T-cells response are unlikely to be a
strong factor for malaria-induced immunosuppression in
the acute phase of the disease in a patient without prior
malaria infection or semi-immunity. Prolonged and pro-
found neutropenia, the single most important and com-
mon risk factor for invasive aspergillosis, was neither
present in this case nor in the patients published.
In contrast to the previously described fatal cases, no other
malaria-related complication such as cerebral malaria or
ARDS was seen in this case, but in two of the other pub-
lished cases. The patient responded quickly to malaria
treatment with rapid clearance of parasites. Invasive
aspergillosis became clinically apparent only after malaria
parasites had been eradicated and after the patient had
started to improve already which is not surprising, as it is
known that malaria-induced immunosuppression occurs
late in the acute phase of the disease. Whether the initial
presentation of pain upon swallowing was already related
to the beginning of the Aspergillus infection is not clear.
The Aspergillus antigen detection with a magnitude below
1.0 was interpreted as negative despite extensive Aspergil-
lus growth in the culture. However, in many settings now
a positive cut-off of 0.5 is used, therefore the maximal
antigen magnitude of 0.8, which was measured after the
positive culture result, would meet the criteria for a posi-
tive result. There are also several studies which showed
that galactomannan ELISA is not as sensitive in invasive
aspergillosis as anticipated [12]. The negative anti-
Aspergillus antibody titre could be an additional marker
for severely impaired immune response to Aspergillus due
to malaria-induced immunosuppression.
Voriconazole is a triazol antifungal that is considered first-
line-treatment for invasive aspergillosis [13]. Because of
the progressive and life-threatening course of the disease,
caspofungin, which belongs to the echinocandins, a new
class of anti-fungals, was administered additionally. Early
recognition and immediate treatment with two potent
anti-fungals may have been the key to successful treat-
ment of invasive aspergillosis and the first described sur-
vival of a patient.
As malaria mostly occurs in low-resource countries with
limited access to diagnostic tools, underreporting of fun-
gal disease complicating malaria may be a problem. With
only four cases reported so far, the incidence seems to be
very low, however. For practical purposes invasive fungal
disease should be considered in malaria patients deterio-
rating after successful anti-malarial treatment. This case
shows that early recognition and immediate treatment in
principle can avert a fatal outcome.
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